↓ Skip to main content

Cannabinoids Modulate Neuronal Activity and Cancer by CB1 and CB2 Receptor-Independent Mechanisms

Overview of attention for article published in Frontiers in Pharmacology, October 2017
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (87th percentile)
  • High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

news
1 news outlet
twitter
9 X users
facebook
1 Facebook page

Citations

dimensions_citation
37 Dimensions

Readers on

mendeley
119 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Cannabinoids Modulate Neuronal Activity and Cancer by CB1 and CB2 Receptor-Independent Mechanisms
Published in
Frontiers in Pharmacology, October 2017
DOI 10.3389/fphar.2017.00720
Pubmed ID
Authors

Ken Soderstrom, Eman Soliman, Rukiyah Van Dross

X Demographics

X Demographics

The data shown below were collected from the profiles of 9 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 119 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 119 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 21 18%
Student > Master 14 12%
Student > Bachelor 13 11%
Student > Ph. D. Student 10 8%
Professor > Associate Professor 5 4%
Other 21 18%
Unknown 35 29%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 19 16%
Pharmacology, Toxicology and Pharmaceutical Science 13 11%
Medicine and Dentistry 12 10%
Neuroscience 9 8%
Agricultural and Biological Sciences 7 6%
Other 22 18%
Unknown 37 31%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 16. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 March 2024.
All research outputs
#2,269,304
of 25,480,126 outputs
Outputs from Frontiers in Pharmacology
#947
of 19,841 outputs
Outputs of similar age
#43,078
of 333,955 outputs
Outputs of similar age from Frontiers in Pharmacology
#13
of 295 outputs
Altmetric has tracked 25,480,126 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 19,841 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.3. This one has done particularly well, scoring higher than 95% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 333,955 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 87% of its contemporaries.
We're also able to compare this research output to 295 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.